Salute e Benessere
Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology
The new LifeSphere Regulatory Platform ecosystem of products includes:
Industry leaders utilizing LifeSphere Regulatory can further power the platforms' capabilities with LifeSphere NavaX , ArisGlobal's next-generation cognitive computing engine, to leverage the latest GenAI and LLM features.
Today, early adopters can leverage GenAI and LLM enhancements that are driving upwards of 50% efficiency gains, including:
In 2023, ArisGlobal launched LifeSphere NavaX , which is now able to power LifeSphere Regulatory for GenAI functionality today – and for future roadmap use cases.
Commenting on the launch, Ann-Marie Orange , CIO & Global Head of R&D shares, "With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we're not stopping."
She continues, "For current LifeSphere Regulatory customers, the new platform will provide an enhanced experience and the ability to deploy the latest technologies, all with simple migration. For organizations looking to drive ROI with a new technology approach to Regulatory Affairs, LifeSphere Regulatory is the most advanced option and a real gamechanger for this industry. The enhanced platform truly revolutionizes critical Regulatory processes and drives better outcomes for life sciences organizations by readying organizations for GenAI and LLM use cases -- we're thrilled to relaunch LifeSphere Regulatory to the market."
ArisGlobal, with a series of new product innovations , is the first life sciences R&D technology company to unveil targeted solutions that make impactful use of GenAI in the industry. The company continues to host the industry-leading GenAI Council , convening top pharmaceutical executives, academia, and AI thought leaders to further fuel adoption of next-generation technologies across life sciences.
To learn more about how LifeSphere Regulatory and NavaX can transform your organization's Regulatory Affairs management, join us for an exclusive webinar on August 7, 2024 .
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States , ArisGlobal has regional offices in Europe , India , Japan , and China . For more updates, follow ArisGlobal on LinkedIn or visit www.arisglobal.com .
View original content: https://www.prnewswire.co.uk/news-releases/newest-version-of-lifesphere-regulatory-platform-allows-organizations-to-leverage-latest-genai-technology-302194048.html